Third Supplement to Master Note Purchase Agreement
Exhibit 4.1
Third Supplement to Master Note Purchase Agreement
Dated as of December 2, 2019
Re:
$100,000,000 2.88% Series 2019B Senior Notes
due December 1, 2029
0000 0xx Xxxxxx Xxxxx
Xxxxxxxxxx, XX 00000
Dated as of December 2, 2019
To the Purchasers named in
Schedule A hereto
Ladies and Gentlemen:
This Third Supplement to Master Note Purchase Agreement (this or the “Third Supplement”) is between Spire Alabama Inc., an Alabama corporation (as successor to Alabama Gas Corporation, the “Company”), and the institutional investors named on Schedule A attached hereto (the “Purchasers”).
Reference is hereby made to that certain Master Note Purchase Agreement between the Company and the purchasers listed on the Schedule A thereto and dated as of June 5, 2015 (the “Master Note Purchase Agreement”), as supplemented by (i) that certain First Supplement to Master Note Purchase Agreement between the Company and the purchasers listed on the Schedule A thereto and dated as of December 1, 2017 (the “First Supplement”) and (ii) that certain Second Supplement to Master Note Purchase Agreement between the Company and the purchasers listed on the Schedule A thereto and dated as of January 15, 2019 (the “Second Supplement”; and, together with the First Supplement and the Master Note Purchase Agreement as amended, restated, supplemented or otherwise modified from time to time, the “Note Purchase Agreement”). All capitalized definitional terms not otherwise defined herein shall have the same meaning as specified in the Note Purchase Agreement. Reference is further made to Section 1.2 of the Note Purchase Agreement which requires that, prior to the delivery of any Additional Notes, the Company and each Additional Purchaser shall execute and deliver a Supplement.
The Company hereby agrees with the Purchasers as follows:
1.The Company has authorized the issue and sale of its $100,000,000 aggregate principal amount 2.88% Series 2019B Senior Notes due December 1, 2029 (the “Series 2019B Notes”). The Series 2019B Notes, together with the Series 2019A Notes, the Series 2017 Notes, and the Series 2015 Notes initially issued pursuant to the Second Supplement, the First Supplement, and the Master Note Purchase Agreement, respectively, and each series of Additional Notes which may from time to time hereafter be issued pursuant to the provisions of Section 1.2 of the Note Purchase Agreement, are collectively referred to as the “Notes” (such term shall also include any such notes issued in substitution therefor pursuant to Section 13 of the Note Purchase Agreement). The Series 2019B Notes shall be substantially in the form set out in Exhibit B hereto with such changes therefrom, if any, as may be approved by the Purchasers and the Company.
2.Subject to the terms and conditions hereof and as set forth in the Note Purchase Agreement and on the basis of the representations and warranties hereinafter set forth, the Company agrees to issue and sell to each Purchaser, and each Purchaser agrees to purchase from the Company, Series 2019B Notes in the principal amount set forth opposite such Purchaser’s name on Schedule A hereto at a price of 100% of the principal amount thereof on the closing date hereinafter mentioned.
3.The execution of this Supplement and the sale and purchase of the Series 2019B Notes to be purchased by each Purchaser shall occur at 10:00 A.M., Chicago time, at a closing (the “Closing”) on December 2, 2019 or on such other Business Day thereafter on or prior to December 31, 2019 as may be agreed upon by the Company and the Purchasers. The Closing shall occur at the offices of Xxxxxxx and Xxxxxx LLP, 000 Xxxx Xxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxx 00000. At the Closing, the Company will deliver to each Purchaser the Series 2019B Notes to be purchased by such Purchaser in the form of a single Series 2019B Note (or such greater number of Series 2019B Notes in denominations of at least $250,000 as such Purchaser may request) dated the date of the Closing and registered in such Purchaser’s name (or in the name of such Purchaser’s nominee), against delivery by such Purchaser to the Company or its order of immediately available funds in the amount of the purchase price therefor by wire transfer of immediately available funds for the account of the Company, with wire instructions to be provided by the Company to the Purchaser at least three Business Days prior to the Closing date in accordance with Section 4. If, at the Closing, the Company shall fail to tender such Series 2019B Notes to any Purchaser as provided above in this Section 3, or any of the conditions specified in Section 4 shall not have been fulfilled to any Purchaser’s satisfaction, such Purchaser shall, at such Purchaser’s election, be relieved of all further obligations under this Supplement, without thereby waiving any rights such Purchaser may have by reason of such failure or such nonfulfillment.
4.The obligation of each Purchaser to purchase and pay for the Series 2019B Notes to be sold to such Purchaser at the Closing is subject to the fulfillment to such Purchaser’s satisfaction, prior to the Closing, of the conditions set forth in Section 4 of the Note Purchase Agreement (giving effect to any changes to the representations and warranties set forth in the Note Purchase Agreement effectuated by this Supplement) with respect to the Series 2019B Notes to be purchased at the Closing, and to the following additional conditions:
(a)Except as supplemented, amended or superseded by the representations and warranties set forth in Exhibit A hereto, each of the representations and warranties of the Company set forth in Section 5 of the Note Purchase Agreement shall be correct as of the date of the Closing and the Company shall have delivered to each Purchaser an Officer’s Certificate, dated the date of the Closing certifying that such condition has been fulfilled.
(b)The Company shall have consummated the sale of the entire principal amount of the Series 2019B Notes scheduled to be sold at the Closing, pursuant to this Supplement.
5.(a) As provided therein, the entire unpaid principal balance of each Series 2019B Note shall be due and payable on December 1, 2029 thereof.
-2-
(b)Optional Prepayments without Make-Whole Amount. Prior to September 1, 2029, the Company may, at its option, in accordance with, and upon notice as provided in, Section 8.2 of the Master Note Purchase Agreement, prepay at any time all, or from time to time any part of, the Series 2019B Notes (but if in part then in a minimum aggregate principal amount of $100,000), at 100% of the principal amount so prepaid, together with interest accrued thereon to the date of such prepayment, plus the Make-Whole Amount determined for the prepayment date with respect to such principal amount. On and after September 1, 2029, the Company may, at its option, upon notice as provided Section 8.2 of the Master Note Purchase Agreement, prepay at any time all the Series 2019B Notes, at 100% of the principal amount so prepaid, together with interest accrued thereon to the date of such prepayment, but without payment of the Make-Whole Amount.
6.The term “Make-Whole Amount” means, with respect to any Series 2019B Note, an amount equal to the excess, if any, of the Discounted Value of the Remaining Scheduled Payments with respect to the Called Principal of such Series 2019B Note over the amount of such Called Principal, provided that the Make-Whole Amount may in no event be less than zero. For the purposes of determining the Make-Whole Amount, the following terms have the following meanings:
“Called Principal” means, with respect to any Series 2019B Note, the principal of such Series 2019B Note that is to be prepaid pursuant to Section 8.2 of the Note Purchase Agreement or has become or is declared to be immediately due and payable pursuant to Section 12.1 of the Note Purchase Agreement, as the context requires.
“Discounted Value” means, with respect to the Called Principal of any Series 2019B Note, the amount obtained by discounting all Remaining Scheduled Payments with respect to such Called Principal from their respective scheduled due dates to the Settlement Date with respect to such Called Principal, in accordance with accepted financial practice and at a discount factor (applied on the same periodic basis as that on which interest on the Series 2019B Notes is payable) equal to the Reinvestment Yield with respect to such Called Principal.
“Reinvestment Yield” means, with respect to the Called Principal of any Series 2019B Note, the sum of (a) 0.50% (50 basis points) plus (b) the yield to maturity implied by the “Ask Yield(s)” reported as of 10:00 A.M. (New York City time) on the second Business Day preceding the Settlement Date with respect to such Called Principal, on the display designated as “Page PX1” (or such other display as may replace Page PX1) on Bloomberg Financial Markets for the most recently issued actively traded on-the-run U.S. Treasury securities (“Reported”) having a maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date. If there are no such U.S. Treasury securities Reported having a maturity equal to such Remaining Average Life, then such implied yield to maturity will be determined by (i) converting U.S. Treasury xxxx quotations to bond equivalent yields in accordance with accepted financial practice and (ii) interpolating linearly between the “Ask Yields” Reported for the applicable most recently issued actively traded on-the-run U.S. Treasury securities with the maturities (1) closest to and greater than such Remaining Average Life and (2) closest to and less than such Remaining Average Life. The Reinvestment Yield shall be rounded to the number of decimal places as appears in the interest rate of such Series 2019B Note.
-3-
If such yields are not Reported or the yields Reported as of such time are not ascertainable (including by way of interpolation), then “Reinvestment Yield” means, with respect to the Called Principal of any Series 2019B Note, the sum of (x) 0.50% (50 basis points) plus (y) the yield to maturity implied by the U.S. Treasury constant maturity yields reported, for the latest day for which such yields have been so reported as of the second Business Day preceding the Settlement Date with respect to such Called Principal, in Federal Reserve Statistical Release H.15 (or any comparable successor publication) for the U.S. Treasury constant maturity having a term equal to the Remaining Average Life of such Called Principal as of such Settlement Date. If there is no such U.S. Treasury constant maturity having a term equal to such Remaining Average Life, such implied yield to maturity will be determined by interpolating linearly between (1) the U.S. Treasury constant maturity so reported with the term closest to and greater than such Remaining Average Life and (2) the U.S. Treasury constant maturity so reported with the term closest to and less than such Remaining Average Life. The Reinvestment Yield shall be rounded to the number of decimal places as appears in the interest rate of such Series 2019B Note.
“Remaining Average Life” means, with respect to any Called Principal, the number of years obtained by dividing (i) such Called Principal into (ii) the sum of the products obtained by multiplying (a) the principal component of each Remaining Scheduled Payment with respect to such Called Principal by (b) the number of years, computed on the basis of a 360-day year comprised of twelve 30-day months and calculated to two decimal places, that will elapse between the Settlement Date with respect to such Called Principal and the scheduled due date of such Remaining Scheduled Payment.
“Remaining Scheduled Payments” means, with respect to the Called Principal of any Series 2019B Note, all payments of such Called Principal and interest thereon that would be due after the Settlement Date with respect to such Called Principal if no payment of such Called Principal were made prior to its scheduled due date, provided that if such Settlement Date is not a date on which interest payments are due to be made under the Series 2019B Notes, then the amount of the next succeeding scheduled interest payment will be reduced by the amount of interest accrued to such Settlement Date and required to be paid on such Settlement Date pursuant to Section 8.2 of the Note Purchase Agreement or Section 12.1 of the Note Purchase Agreement.
“Settlement Date” means, with respect to the Called Principal of any Series 2019B Note, the date on which such Called Principal is to be prepaid pursuant to Section 8.2 of the Note Purchase Agreement or has become or is declared to be immediately due and payable pursuant to Section 12.1 of the Note Purchase Agreement, as the context requires.
7.For the purpose of the Note Purchase Agreement and this Supplement, the terms below have the following meanings with respect to any holder of a Series 2019B Note:
“Parent” shall mean Spire Inc., a Missouri corporation.
“Xxxxx Facility” means the Loan Agreement, dated as of December 14, 2016, as amended by the First Amendment to Loan Agreement dated as of October 31, 2018 or as it may be subsequently be amended, renewed, restated, replaced or otherwise modified from time to time, amongst the Parent, the Company, Spire Missouri Inc., a Missouri corporation, the banks from
-4-
time to time party thereto and Xxxxx Fargo Bank, National Association, as administrative agent for the banks, or any successor thereto.
8.Each Purchaser represents and warrants that the representations and warranties set forth in Section 6 of the Note Purchase Agreement are true and correct on the date of the Closing with respect to the purchase of the Series 2019B Notes by such Purchaser.
9.Except as otherwise required by applicable law, the Company agrees that it will not withhold from any applicable payment to be made to a holder of a Note that is not a United States Person any tax so long as such holder shall have delivered to the Company (in such number of copies as shall be requested) on or about the date on which such holder becomes a holder under this Supplement (and from time to time thereafter upon the reasonable request of the Company), executed copies of IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable, as well as the applicable U.S. Tax Compliance Certificate substantially in the form attached as Exhibit C, in both cases correctly completed and executed.
10.Subject to the terms of this Supplement, the Company and each Purchaser agree to be bound by and comply with the terms and provisions of the Note Purchase Agreement as fully and completely as if such Purchaser were an original signatory to the Note Purchase Agreement.
* * * * *
-5-
The execution hereof shall constitute a contract between the Company and the Purchasers for the uses and purposes hereinabove set forth, and this agreement may be executed in any number of counterparts, each executed counterpart constituting an original but all together only one agreement.
By /s/ Xxxx Xxxxxxx
|
|
Name: Xxxx Xxxxxxx |
|
|
Title: Treasurer |
Signature page to Third Supplement to Master Note Purchase Agreement
Accepted as of December 2, 2019
|
|
The Northwestern Mutual Life Insurance Company |
|
|
|
|
|
|
|
By: |
Northwestern Mutual Investment Management Company, LLC, its investment advisor |
|
|
|
|
|
|
By: |
/s/ Xxxxxx Xxxxx |
|
|
|
Name: Xxxxxx Xxxxx |
|
|
|
Title: Managing Director |
|
|
|
|
|
|
|
|
|
|
The Northwestern Mutual Life Insurance Company for its Group Annuity Separate Account |
|
|
|
|
|
|
|
By: |
/s/ Xxxxxx Xxxxx |
|
|
|
Name: Xxxxxx Xxxxx |
|
|
|
Title: Authorized Representative |
Signature page to Third Supplement to Master Note Purchase Agreement
Accepted as of December 2, 2019
|
|
MetLife Insurance K.K. |
|
|
|
by MetLife Investment Management, LLC, Its Investment Manager |
|
|
|
|
|
|
|
By: |
/s/ Xxxx Xxxxxxx |
|
|
Name: Xxxx Xxxxxxx |
|
|
|
Title: Authorized Signatory |
|
|
|
|
|
|
|
|
|
|
|
Brighthouse Life Insurance Company |
|
|
|
by MetLife Investment Management, LLC, Its Investment Manager |
|
|
|
|
|
|
|
By: |
/s/ Xxxxxx X. Xxxxxxx |
|
|
Name: Xxxxxx X. Xxxxxxx |
|
|
|
Title: Authorized Signatory |
|
|
|
|
|
|
|
|
|
|
|
RSUI Indemnity Company |
|
|
|
by MetLife Investment Management, LLC, Its Investment Manager |
|
|
|
|
|
|
|
By: |
/s/ Xxxxx Xxxxxxxxxx |
|
|
Name: Xxxxx Xxxxxxxxxx |
|
|
|
Title: Authorized Signatory |
|
|
|
|
|
|
|
|
|
|
|
Swiss Re Life & Health America Inc. |
|
|
|
by MetLife Investment Management, LLC, Its Investment Manager |
|
|
|
|
|
|
|
By: |
/s/ Xxxxxx X. Xxxxxxx |
|
|
Name: Xxxxxx X. Xxxxxxx |
|
|
|
Title: Authorized Signatory |
|
|
|
|
|
|
|
|
|
Signature page to Third Supplement to Master Note Purchase Agreement
|
|
Pensionskasse des Bundes PUBLICA |
|
|
|
by MetLife Investment Management Limited, as Investment Manager |
|
|
|
|
|
|
|
By: |
/s/ Xxxxxxx Xxxxxxxxx |
|
|
Name: Xxxxxxx Xxxxxxxxx |
|
|
|
Title: Authorised Signatory |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature page to Third Supplement to Master Note Purchase Agreement
Accepted as of December 2, 2019
|
|
New York Life Insurance Company |
|
|
|
|
|
|
|
By |
/s/ Xxxxxxx X. Xxxxxx |
|
|
|
Name: Xxxxxxx X. Xxxxxx |
|
|
|
Title: Corporate Vice President |
|
|
|
|
|
|
|
|
|
|
New York Life Insurance and Annuity Corporation |
|
|
|
|
|
|
|
By: |
NYL Investors LLC, its Investment Manager |
|
|
|
|
|
|
By |
/s/ Xxxxxxx X. Xxxxxx |
|
|
|
Name: Xxxxxxx X. Xxxxxx |
|
|
|
Title: Senior Director |
|
|
|
|
|
|
|
|
|
|
New York Life Insurance and Annuity Corporation Institutionally Owned Life Insurance Separate Account (BOLI 30C) |
|
|
|
|
|
|
|
By: |
NYL Investors LLC, its Investment Manager |
|
|
|
|
|
|
By |
/s/ Xxxxxxx X. Xxxxxx |
|
|
|
Name: Xxxxxxx X. Xxxxxx |
|
|
|
Title: Senior Director |
Signature page to Third Supplement to Master Note Purchase Agreement
Accepted as of December 2, 0000
|
|
XXX XXXX XX XXX XXXX MELLON, A BANKING CORPORATION ORGANIZED UNDER THE LAWS OF NEW YORK, NOT IT ITS INDIVIDUAL CAPACITY BUT SOLELY AS TRUSTEE UNDER THAT CERTAIN TRUST AGREEMENT DATED AS OF JULY 1ST, 2015 BETWEEN NEW YORK LIFE INSURANCE COMPANY, AS GRANTOR, XXXX XXXXXXX LIFE INSURANCE COMPANY (U.S.A.), AS BENEFICIARY, XXXX XXXXXXX LIFE INSURANCE COMPANY OF NEW YORK, AS BENEFICIARY, AND THE BANK OF NEW YORK MELLON, AS TRUSTEE |
|
|
|
|
|
|
|
By: |
New York Life Insurance Company, its attorney-in-fact |
|
|
|
|
|
|
By |
/s/ Xxxxxxx X. Xxxxxx |
|
|
|
Name: Xxxxxxx X. Xxxxxx |
|
|
|
Title: Corporate Vice President |
Signature page to Third Supplement to Master Note Purchase Agreement
Accepted as of December 2, 2019
|
|
American United Life Insurance Company |
|
|
|
|
|
|
|
By |
/s/ Xxxxx X. Xxxxxxxxxxxx |
|
|
Name: Xxxxx X. Xxxxxxxxxxxx |
|
|
|
Title: VP, Fixed Income Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature page to Third Supplement to Master Note Purchase Agreement
Information Relating to Purchasers
|
|
Principal Amount of Notes to be Purchased
|
|
The Northwestern Mutual Life Insurance Company |
$51,480,000 |
|
I. The Northwestern Mutual Life Insurance Company
|
|
II. All payments on account of Notes held by such Purchaser shall be made by wire transfer of immediately available funds, providing sufficient information to identify the source of the transfer, the amount of the interest and/or redemption (as applicable) and the identity of the security as to which payment is being made.
Please contact our Treasury & Investment Operations Department to securely obtain wire transfer instructions for The Northwestern Mutual Life Insurance Company.
E-mail: xxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx Phone: (000) 000-0000
|
|
III. All notices with respect to confirmation of payments on account of the Notes shall be delivered or mailed to:
The Northwestern Mutual Life Insurance Company 000 Xxxx Xxxxxxxxx Xxxxxx Xxxxxxxxx, XX 00000 Attention: Investment Operations E-mail: xxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx Phone: (000) 000-0000
|
|
IV. All other communications including any permitted electronic delivery of financial and business information (or any notices related thereto) shall be delivered or mailed to:
The Northwestern Mutual Life Insurance Company 000 Xxxx Xxxxxxxxx Xxxxxx Xxxxxxxxx, XX 00000 Attention: Securities Department E-mail: xxxxxxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx
With a copy to:
The Northwestern Mutual Life Insurance Company 000 Xxxx Xxxxxxxxx Xxxxxx Xxxxxxxxx, XX 00000 Attention: Xxxxxxx X. Xxxxxxx, Managing Director Xxxxxx X. Xxxxxx, Director E-mail: xxxxxxxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx xxxxxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx |
Schedule A
(to Supplement)
|
V. Address for delivery of the Notes:
The Northwestern Mutual Life Insurance Company 000 Xxxx Xxxxxxxxx Xxxxxx Xxxxxxxxx, XX 00000 Attention: Xxxxxx X. Xxxxx
|
|
VI. If posted to IntraLinks or another document repository/hosted website, send to:
Email: xxxxxxxxxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx
|
|
VII. Tax Identification No.: 00-0000000
|
A-2
|
|
Principal Amount of Notes to be Purchased
|
|
The Northwestern Mutual Life Insurance Company for its Group Annuity Separate Account |
$520,000 |
|
I. The Northwestern Mutual Life Insurance Company for its Group Annuity Separate Account
|
|
II. All payments on account of Notes held by such Purchaser shall be made by wire transfer of immediately available funds, providing sufficient information to identify the source of the transfer, the amount of the dividend and/or redemption (as applicable) and the identity of the security as to which payment is being made.
Please contact our Treasury & Investment Operations Department to securely obtain wire transfer instructions for The Northwestern Mutual Life Insurance Company for its Group Annuity Separate Account.
E-mail: xxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx Phone: (000) 000-0000
|
|
III. All notices with respect to confirmation of payments on account of the Notes shall be delivered or mailed to:
The Northwestern Mutual Life Insurance Company for its Group Annuity Separate Account 000 Xxxx Xxxxxxxxx Xxxxxx Xxxxxxxxx, XX 00000 Attention: Investment Operations E-mail: xxxxxxxx@xxxxxxxxxxxxxxxxxx.xxx Phone: (000) 000-0000
|
A-3
A-4
|
|
Principal Amount of Notes to be Purchased
|
|
METLIFE INSURANCE K.K. 0-0, Xxxxxxx, Xxxxxxx-xx Xxxxx, 000-0000 XXXXX |
$ 8,800,000 |
(portfolio ADK,ADL,ADN,ADU,ADV,AEB,AEF,AEM,CUB,CUC,CUD,CUE,DGN,
DHN,DHO,DHP,DJG,DJH,MM1,TT3,TT4,TT9,UU2,UU4 - for USD non-GGA)
(Securities to be registered in the name of MetLife Insurance K.K.)
(1) All scheduled payments of principal and interest by wire transfer of immediately available funds to:
|
Beneficiary Bank: |
The HongKong and Shanghai Banking Corporation Ltd |
|
Beneficiary Bank BIC: |
XXXXXXXXXXX |
|
Beneficiary Account No.: |
000-000000-000 |
|
Beneficiary Name: |
MetLife Insurance K.K. |
|
Intermediary Bank: |
HSBC BANK USA NA |
|
Intermediary Bank BIC: |
XXXXXX00 |
|
Beneficiary Bank Account No.: |
000044415 |
|
Additional Information: |
Fedwire No.: 000000000 CHIPS No:0108 |
|
|
|
|
Ref: |
PPN 84858# AD5 – SPIRE ALABAMA INC; 2.88% due 01-Dec-2029 |
with sufficient information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise. For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder, and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
(2) All notices and communications:
MetLife Asset Management Corp. (Japan)
Administration Department
Tokyo Garden Terrace Kioicho Kioi Tower 25F
0-0, Xxxxxxx, Xxxxxxx-xx, Xxxxx 000-0000 Xxxxx
Attention: Administration Dept. Manager
Email: xxxxx@xxxxxxx.xx.xx
With a copy to:
MetLife Insurance K.K.
c/o MetLife Investment Management, LLC
Investments, Private Placements
Xxx XxxXxxx Xxx
Xxxxxxxx, Xxx Xxxxxx 00000
Attention: Xxxxx Xxxxxx, Associate Director; Xxxxxxx Xxxxx, Associate
Emails: XXXXxxxxxxxxx@xxxxxxx.xxx; xxxxxxx@xxxxxxx.xxx; xxxxxxx.x.xxxxx@xxxxxxx.xxx; XxxXxxXxxxxxxxxx@xxxxxxx.xxx
A-5
With another copy OTHER than with respect to deliveries of financial statements to:
MetLife Insurance K.K.
c/o MetLife Investment Management, LLC, Investments Law
Xxx XxxXxxx Xxx
Xxxxxxxx, Xxx Xxxxxx 00000
Attention: Chief Counsel-Investments Law (PRIV)
Email: xxx_xxxxxx_xxx@xxxxxxx.xxx
(3) Original notes delivered to:
MetLife Insurance K.K.
c/o MetLife Investment Management, LLC, Investments Law
Xxx XxxXxxx Xxx
Xxxxxxxx, Xxx Xxxxxx 00000
Attention: Xxxxxx Xxxxx-Xxxx, Senior Corporate Counsel
(4) Taxpayer I.D. Number: 00-0000000 (USA) and 00000000 (Japan)
(5) Tax Jurisdiction: Japan
(6) UK Passport Treaty Number (if applicable): 43/M/359828/DTTP
|
Audit Requests: Soft copy to XxxxxXxxxxxxx.XxxXxxxxxxxxx@xxxxxxx.xxx or hard copy to: Metropolitan Life Insurance Company, Attn: Private Placements Operations (ATTN: Audit Confirmations), 00000 Xxxxx Xxxx Xxxxx – 0xx Xxxxx, Xxxxx, XX 00000 |
A-6
|
|
Principal Amount of Notes to be Purchased
|
|
Swiss Re Life & Health America Inc. 000 Xxxx Xxxxxx Xxxxxx, Xxx Xxxx 00000 Xxxxxx Xxxxxx |
$ 4,500,000 |
(portfolio code GRA for USD)
Securities to be registered in the name of Swiss Re Life & Health America Inc.
|
(1) |
All scheduled payments of principal and interest by wire transfer of immediately available funds to: |
|
USD |
|
|
Bank |
XX Xxxxxx Xxxxx Bank, New York |
|
Swift |
XXXXXX00 |
|
ABA |
000000000 |
|
Beneficiary Account No. |
9009000127 |
|
Beneficiary Account Name |
JPMorgan North America Insurance |
|
Account No. |
G 23001 |
|
Account |
SL - Private Placements – Metlife |
|
Ref: |
PPN 84858# AD5 – SPIRE ALABAMA INC; 2.88% due 01-Dec-2029 |
with sufficient information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise.
For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder, and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
|
(2) |
All notices and communications: |
Swiss Re Life & Health America Inc.
c/o MetLife Investment Advisors, LLC
Investments, Private Placements
Xxx XxxXxxx Xxx
Xxxxxxxx, XX 00000
Attention: Xxxxx Xxxxxx, Associate Director; Xxxxxxx Xxxxx, Associate
Facsimile (000) 000-0000
Emails: XXXXxxxxxxxxx@xxxxxxx.xxx and xxxxxxx@xxxxxxx.xxx; xxxxxxx.x.xxxxx@xxxxxxx.xxx;
and
Swiss Re Life & Health America Inc.
000 Xxxx Xxxxxx
Xxxxxx, Xxx Xxxx 00000
Xxxxxx Xxxxxx
Attention: Xxxx Xxxxxxx (Xxxx_Xxxxxxx@xxxxxxx.xxx)
A-7
With a copy OTHER than with respect to deliveries of financial statements to:
|
|
Swiss Re Life & Health America Inc. c/o MetLife Investment Advisors, LLC Xxx XxxXxxx Xxx Xxxxxxxx, XX 00000 Attention: Chief Counsel-Investments Law (PRIV) Email: xxx_xxxxxx_xxx@xxxxxxx.xxx |
|
(3) |
Original notes delivered to: |
For overnight or standard mail
JPMorgan Chase Bank, N.A.
4 Chase Xxxxxxxxx Xxxxxx
0xx Xxxxx
Xxxxxxxx, Xxx Xxxx 00000-0000
Attention: Physical Receive Department
For Street Deliveries (via messenger or walk up)
JPMorgan Chase Bank, N.A.
4 Chase Metrotech Center
1st Floor, Window 5
Brooklyn, New York 11245-0001
Attention: Physical Receive Department
(Use Xxxxxxxxxx Street Entrance)
With COPIES OF THE NOTES emailed to XXX.XXX.XXXXX@xxxxxxx.xxx and
xxxxxx.xxxxx-xxxx@xxxxxxx.xxx
|
(4) |
Taxpayer I.D. Number: 00-0000000 |
|
(5) |
UK Passport Treaty Number (if applicable): N/A |
A-8
|
|
Principal Amount of Notes to be Purchased
|
|
Pensionskasse des Bundes PUBLICA Attn. Asset Management 0000 Xxxx, Xxxxxxxxxxx |
$ 3,300,000 |
(portfolio code PB1 for USD)
Securities to be registered in the name of Pensionskasse des Bundes PUBLICA
|
(6) |
All scheduled payments of principal and interest by wire transfer of immediately available funds to: |
|
Currency: |
USD |
|
Bank Name: |
JPMORGAN CHASE BANK, N.A. |
|
SWIFT: |
XXXXXX00 |
|
Account No.: |
001 0 962009 |
|
ABA: |
000000000 |
|
Name: |
CHASGB2L |
|
FFC: |
XX00XXXX00000000000000 |
|
Name: |
PD_CORP_MET_DIR |
|
Ref: |
EAQ51 and PPN 84858# AD5 – SPIRE ALABAMA INC; 2.88% due 01-Dec-2029 |
with sufficient information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise.
For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder, and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
|
(7) |
All notices and communications: |
Publica
c/o MetLife Investment Management Limited
Investments, Private Placements
Xxx XxxXxxx Xxx
Xxxxxxxx, XX 00000
Attention: Xxxxx Xxxxxx, Associate Director; Xxxxxxx Xxxxx, Associate
Emails: XXXXxxxxxxxxx@xxxxxxx.xxx and xxxxxxx@xxxxxxx.xxx; xxxxxxx.x.xxxxx@xxxxxxx.xxx;
With a copy OTHER than with respect to deliveries of financial statements to:
Pensionskasse des Bundes PUBLICA
Attn. Asset Management
Xxxxxxxxxxxx 00
0000 Xxxx, Xxxxxxxxxxx
Facsimile: x00 00 000 00 00
and
|
Publica c/o MetLife Investment Management Limited Xxx XxxXxxx Xxx Xxxxxxxx, XX 00000 Attention: Chief Counsel-Investments Law (PRIV) Email: xxx_xxxxxx_xxx@xxxxxxx.xxx |
A-9
JPMorgan Chase Bank, N.A.
4 Chase Xxxxxxxxx Xxxxxx, 0xx Xxxxx
Xxxxxxxx, Xxx Xxxx 00000-0000
Attention: Physical Receive Department
Reference Account: GTI EAQ51
Reference: Account Name - PD_CORP_MET_DIR
With COPIES OF THE NOTES emailed to xxxxxx.xxxxx-xxxx@xxxxxxx.xxx
|
(9) |
Taxpayer I.D. Number: ZPV 230’763’575 |
|
(10) |
Tax Jurisdiction: Switzerland |
|
(11) |
UK Passport Treaty Number (if applicable): 6/P/344506/DTTP |
A-10
|
|
Principal Amount of Notes to be Purchased
|
|
BRIGHTHOUSE LIFE INSURANCE COMPANY 00000 Xxxxx Xxxxxxxxx Xxxxx Xxxx Xxxxxxxxx, XX 00000 |
$ 2,200,000 |
(Portfolio 7PP)
(Securities to be registered in the name of Brighthouse Life Insurance Company)
(1)All scheduled payments of principal and interest by wire transfer of immediately available funds to:
|
Bank Name: |
NORTHERN CHGO/Trust |
|
ABA Routing #: |
000000000 |
|
Credit Wire Account# |
5186061000 |
|
Further Credit Account Name: |
BLIC MM 7YB_PP |
|
Further Credit Account Number: |
17-66316 |
|
Ref: |
PPN 84858# AD5 – SPIRE ALABAMA INC; 2.88% due 01-Dec-2029 |
with sufficient information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise.
For all payments other than scheduled payments of principal and interest, the Company shall seek instructions
from the holder, and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
(2)All notices and communications:
Brighthouse Life Insurance Company
c/o MetLife Investment Advisors, LLC, Investments - Private Placements
Xxx XxxXxxx Xxx
Xxxxxxxx, Xxx Xxxxxx 00000
Attention: Xxxxx Xxxxxx, Associate Director; Xxxxxxx Xxxxx, Associate
Emails: XXXXxxxxxxxxx@xxxxxxx.xxx and xxxxxxx@xxxxxxx.xxx; xxxxxxx.x.xxxxx@xxxxxxx.xxx;
With a copy OTHER than with respect to deliveries of financial statements to:
Brighthouse Life Insurance Company
c/o MetLife Investment Advisors, LLC, Investments Law
Xxx XxxXxxx Xxx
Xxxxxxxx, Xxx Xxxxxx 00000
Attention: Chief Counsel-Investments Law (PRIV)
Email: xxx_xxxxxx_xxx@xxxxxxx.xxx
(3)Original notes delivered to:
Northern Trust
Attn: Xxxxxx X. Xxxxxx
00 Xxxxx Xx Xxxxx Xxxxxx, X-00
Xxxxxxx, Xxxxxxxx 00000
With COPIES OF THE NOTES emailed to xxxxxx.xxxxx-xxxx@xxxxxxx.xxx
A-11
(4)Taxpayer I.D. Number: 00-0000000
(5)Tax Jurisdiction: United States
(6)Tax Classification: C Corporation
(7)UK Passport Treaty Number (if applicable): 13/B/61653/DTTP
A-12
|
|
Principal Amount of Notes to be Purchased
|
|
RSUI Indemnity Company 000 Xxxx Xxxxx Xxxxx Xxxx, Xxxxx 0000 Xxxxxxx, XX 00000-0000 |
$ 1,200,000 |
(Securities to be registered in the name of Hare & Co., LLC)
(1) All scheduled payments of principal and interest by wire transfer of immediately available funds to:
|
Bank Name: |
The Bank of New York Mellon |
|
|
SWIFT: |
XXXXXX0X or |
|
|
ABA: |
021 000 018 |
|
|
Account No.: |
GLA 111566 |
|
|
Sort Code: |
|
|
|
FFC: |
301476 |
|
|
Ref: |
PPN 84858# AD5 – SPIRE ALABAMA INC; 2.88% due 01-Dec-2029 |
|
with sufficient information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise.
For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder, and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
(2) All notices and communications:
RSUI Indemnity Company
c/o MetLife Investment Advisors, LLC
Investments, Private Placements
Xxx XxxXxxx Xxx
Xxxxxxxx, Xxx Xxxxxx 00000
Attention: Xxxxx Xxxxxx, Associate Director; Xxxxxxx Xxxxx, Associate
Facsimile (000) 000-0000
Emails: PPUCompliance @xxxxxxx.xxx and xxxxxxx@xxxxxxx.xxx; xxxxxxx.x.xxxxx@xxxxxxx.xxx;
With a copy OTHER than with respect to deliveries of financial statements to:
Xxxxxxx X. Xxxxxxxx, CPA, CPCU
Senior Vice President, CFO
RSUI Group, Inc.
000 Xxxx Xxxxx Xxxxx Xxxx, Xxxxx 0000
Xxxxxxx, XX 00000-0000
000 000-0000 Direct
(3) Original notes delivered to:
The Depository Trust Company
000 Xxxxxxxxxx Xxxx – 0xx Xxxxx
Xxxxxx Xxxx, XX 00000
Attn: BNY Mellon/Branch Deposit Department
REF: TRUST A/C# 301476
A-13
Please include in the cover letter accompanying the Notes a reference to the Purchaser's account number (RSUI Indemnity Company Private Placements; Account Number: 301476)
With COPIES OF THE NOTES emailed to xxxxxx.xxxxx-xxxx@xxxxxxx.xxx
(4) Taxpayer I.D. Number: 00-0000000
(5) Tax Jurisdiction: United States
(6) UK Passport Treaty Number (if applicable): [_______________________]
A-14
|
|
Principal Amount of Notes to be Purchased
|
|
New York Life Insurance and Annuity Corporation |
$10,750,000
|
See instructions on following page.
Also, with respect to any notices delivered electronically under clause 2 in the attached, please also send a copy to: xxxxxxxx_xxxx@xxxxxxxxxxxx.xxx.
A-15
A-16
|
|
Principal Amount of Notes to be Purchased
|
|
New York Life Insurance Company |
$7,250,000
|
See instructions on following page.
Also, with respect to any notices delivered electronically under clause 2 in the attached, please also send a copy to: xxxxxxxx_xxxx@xxxxxxxxxxxx.xxx.
A-17
A-18
|
|
Principal Amount of Notes to be Purchased
|
|
The Bank of New York Mellon, a banking corporation organized under the laws of New York, not in its individual capacity but solely as Trustee under that certain Trust Agreement dated as of July 1st, 2015 between New York Life Insurance Company, as Grantor, Xxxx Xxxxxxx Life Insurance Company (U.S.A.), as Beneficiary, Xxxx Xxxxxxx Life Insurance Company of New York, as Beneficiary, and The Bank of New York Mellon, as Trustee
Hare & Co., LLC (as nominee for the NYL- JH Trust) |
$1,500,000 |
See instructions on following page.
Also, with respect to any notices delivered electronically under clause 2 in the attached, please also send a copy to: xxxxxxxx_xxxx@xxxxxxxxxxxx.xxx.
X-00
X-00
X-00
|
|
Principal Amount of Notes to be Purchased
|
|
New York Life Insurance and Annuity Corporation Institutionally Owned Life Insurance Separate Account (BOLI30C) |
$500,000
|
See instructions on following page.
Also, with respect to any notices delivered electronically under clause 2 in the attached, please also send a copy to: xxxxxxxx_xxxx@xxxxxxxxxxxx.xxx.
A-22
A-23
|
|
Principal Amount of Notes to be Purchased
|
|
American United Life Insurance Company |
$8,000,000 |
|
Purchaser: |
American United Life Insurance Company |
|
|
|
|
Issuer: |
Spire Alabama, Inc. |
|
|
|
|
Issuing: |
Senior Note(s) due 2029 |
|
|
|
|
Closing: |
12/02/2019 |
|
|
|
|
Issue: |
2.88% |
|
|
|
|
Amount: |
$8,000,000.00 |
The original note(s) should be sent to:
The Depository Trust Company
Attn: BNY Mellon/Branch Deposit Dept.
Acct # 186683 American United Life Ins. Co.
000 Xxxxxxxxxx Xxxx. – 0xx Xxxxx
Xxxxxx Xxxx, XX 00000
Please send all POST-CLOSING documentation to:
American United Life Insurance Company
Attn: Xxxx Xxxxxxx, Securities Department
One American Square, Xxxxx 0000
Xxxx Xxxxxx Xxx 000
Xxxxxxxxxxxx, XX 00000
xxxx.xxxxxxx@xxxxxxxxxx.xxx
|
Payment: |
Spire Alabama, Inc. shall make payment of principal and interest on the note(s) in |
AMERICAN UNITED LIFE INSURANCE COMPANY
Bank of New York
ABA #: 000000000
Credit Account: GLA111566
Account Name: American United Life Insurance Company
Account #: 186683
P & I Breakdown: (Insert)
Re: (Insert PPN 84858# AD5 and credit name here)
Payments should contain sufficient information to identify the breakdown of principal and interest and should identify the full description of the note(s) and the payment date.
The United States Tax I.D. Number of American United Life Insurance Company is 00-0000000.
A-24
Supplemental Representations
The Company represents and warrants to each Purchaser that except as hereinafter set forth in this Exhibit A, each of the representations and warranties set forth in Section 5 of the Note Purchase Agreement is true and correct in all Material respects as of the date of the Closing with respect to the Series 2019B Notes with the same force and effect as if each reference to “Series 2015 Notes” set forth therein was modified to refer to the “Series 2019B Notes” and each reference to “this Agreement” therein was modified to refer to the Note Purchase Agreement as supplemented by the Third Supplement. The Section references hereinafter set forth correspond to the similar sections of the Note Purchase Agreement which are supplemented hereby:
Section 5.3.Disclosure. The Company has delivered to each Purchaser a copy of its financial statements listed in Schedule 5.5. The Note Purchase Agreement, the Third Supplement, and the documents, certificates or other writings delivered to the Purchasers by or on behalf of the Company in connection with the transactions contemplated by the Note Purchase Agreement and the Third Supplement and identified in Schedule 5.3, and the financial statements listed in Schedule 5.5 (the Note Purchase Agreement, the Third Supplement, and such documents, certificates or other writings and such financial statements delivered to each Purchaser prior to August 14, 2019 being referred to, collectively, as the “Disclosure Documents”), taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made; provided that, with respect to projections, budgets and other estimates, the Company represents only that such information was prepared in good faith based upon assumptions believed to be reasonable at the time. Except as disclosed in the Disclosure Documents, since September 30, 2019, there has been no change in the financial condition, operations, business or properties of the Company or any of its Subsidiaries except changes that individually or in the aggregate would not reasonably be expected to have a Material Adverse Effect.
Section 5.4.Organization and Ownership of Shares of Subsidiaries. Schedule 5.4 to the Third Supplement is (except as noted therein), as of the date of the Closing a complete and correct list of the Company’s Subsidiaries, showing, as to each Subsidiary, the correct name thereof, the jurisdiction of its organization, and the percentage of shares of each class of its Capital Stock outstanding owned by the Company and each other Subsidiary.
Section 5.13.Private Offering by the Company. Neither the Company nor anyone acting on its behalf has offered the Series 2019B Notes or any similar Securities for sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any Person other than the Purchasers and not more than twenty-six (26) other Institutional Investors, each of which has been offered the Series 2019B Notes at a private sale for investment. Neither the Company nor anyone acting on its behalf has taken, or will take, any action that would subject the issuance or sale of the Series 2019B Notes to the registration requirements of Section 5 of the Securities Act or to the registration requirements of any securities or blue sky laws of any applicable jurisdiction.
Exhibit A
(to Supplement)
Section 5.14.Use of Proceeds; Margin Regulations. The Company will apply the proceeds of the sale of the Series 2019B Notes to refinance existing debt and for general corporate purposes. No part of the proceeds from the sale of the Series 2019B Notes under the Third Supplement will be used, directly or indirectly, for the purpose of buying or carrying any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System (12 CFR 221), or for the purpose of buying or carrying or trading in any Securities under such circumstances as to involve the Company in a violation of Regulation X of said Board (12 CFR 224) or to involve any broker or dealer in a violation of Regulation T of said Board (12 CFR 220). Margin stock does not constitute more than 15% of the value of the consolidated assets of the Company and its Subsidiaries and the Company does not have any present intention that margin stock will constitute more than 15% of the value of such assets. As used in this Section 5.14, the terms “margin stock” and “purpose of buying or carrying” shall have the meanings assigned to them in said Regulation U.
Section 5.15.Existing Indebtedness. Except as described therein, Schedule 5.15 to the Third Supplement sets forth a complete and correct list of all outstanding Indebtedness of the Company and its Subsidiaries as of June 30, 2019 (including a description of the obligors and obligees, principal amount outstanding and collateral therefor, if any, and Guaranty thereof, if any), since which date there has been no Material change in the amounts, interest rates, sinking funds, installment payments or maturities of the Indebtedness of the Company or its Subsidiaries (other than as permitted hereunder). Neither the Company nor any Subsidiary is in default and no waiver of default is currently in effect, in the payment of any principal or interest on any Indebtedness of the Company or such Subsidiary and no event or condition exists with respect to any Indebtedness of the Company or any Subsidiary the outstanding principal amount of which exceeds $10,000,000 that would permit (or that with notice or the lapse of time, or both, would permit) one or more Persons to cause such Indebtedness to become due and payable before its stated maturity or before its regularly scheduled dates of payment.
A-2
Spire Alabama Inc.
2.88% Series 2019B Senior Note, due December 1, 2029
|
No. 2019B-[__] |
[Date] |
|
$[_______] |
PPN 84858# AD5 |
For Value Received, the undersigned, Spire Alabama Inc. (herein called the “Company”), a corporation organized and existing under the laws of the State of Alabama, hereby promises to pay to [____________], or its registered assigns, the principal sum of [_____________________] Dollars (or so much thereof as shall not have been prepaid) on December 1, 2029, with interest (computed on the basis of a 360-day year of twelve 30‑day months) (a) on the unpaid balance hereof at the rate of 2.88% per annum from the date hereof, payable semi-annually, on the 1st day of December and June in each year, commencing on June 1, 2020 and thereafter on the December 1 or June 1 next succeeding the date hereof, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, on any overdue payment (including any overdue prepayment) of principal, any overdue payment of interest and any overdue payment of any Make‑Whole Amount, payable semi‑annually as aforesaid (or, at the option of the registered holder hereof, on demand), at a rate per annum from time to time equal to the greater of (i) 4.88% and (ii) 2.0% over the rate of interest publicly announced by Chase Bank, N.A. from time to time in New York, New York as its “base” or “prime” rate.
Payments of principal of, interest on and any Make-Whole Amount with respect to this Note are to be made in lawful money of the United States of America at Commerce Bank or at such other place as the Company shall have designated by written notice to the holder of this Note as provided in the Note Purchase Agreement referred to below.
This Note is one of a series of Senior Notes (herein called the “Notes”) issued pursuant to a Third Supplement dated as of December 2, 2019 to the Master Note Purchase Agreement, dated as of June 5, 2015 (as from time to time amended, restated and supplemented, the “Note Purchase Agreement”), between the Company and the respective Purchasers named therein and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the provisions of the Note Purchase Agreement, including, without limitation, the confidentiality provisions set forth in Section 20 of the Note Purchase Agreement and (ii) made the representations set forth in Section 6.1 and Section 6.2 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the Note Purchase Agreement.
This Note is a registered Note and, as provided in the Note Purchase Agreement, upon surrender of this Note for registration of transfer, accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the name of, the
Exhibit B
(to Supplement)
transferee. Prior to due presentment for registration of transfer, the Company may treat the Person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the Company will not be affected by any notice to the contrary.
This Note is subject to optional prepayment, in whole or from time to time in part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise.
If an Event of Default occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement.
[Signature Page Follows]
B-2
This Note shall be construed and enforced in accordance with, and the rights of the Company and the holder of this Note shall be governed by, the law of the State of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State.
Spire Alabama Inc.
By
|
|
Name: |
|
|
Title: |
B-3
U.S. TAX COMPLIANCE CERTIFICATE
Reference is hereby made to that certain Master Note Purchase Agreement between the Company and the purchasers listed on the Schedule A thereto and dated as of June 5, 2015 (the “Master Note Purchase Agreement”), as supplemented by (i) that certain First Supplement to Master Note Purchase Agreement between the Company and the purchasers listed on the Schedule A thereto and dated as of December 1, 2017 (the “First Supplement”), (ii) that certain Second Supplement to Master Note Purchase Agreement between the Company and the purchasers listed on the Schedule A thereto and dated as of January 15, 2019 (the “Second Supplement”), and (iii) that certain Third Supplement to Master Note Purchase Agreement between the Company and the purchasers listed on the Schedule A thereto and dated as of December 2, 2019 (the “Third Supplement”; and, together with the First Supplement, the Second Supplement, and the Master Note Purchase Agreement as amended, restated, supplemented or otherwise modified from time to time, the “Note Purchase Agreement”). Unless otherwise defined herein, capitalized terms defined in the Note Purchase Agreement and used herein have the meanings given to them in the Note Purchase Agreement.
Pursuant to the provisions of Section 9 of the Third Supplement, the undersigned hereby certifies that:
|
|
(i) |
it is the sole record and beneficial owner of the Notes in respect of which it is providing this certificate; |
|
|
(ii) |
it is not a bank within the meaning of Section 881(c)(3)(A) of the Code; |
|
|
(iii) |
it is not a ten percent shareholder of the Company within the meaning of Section 871(h)(3)(B) of the Code; and |
|
|
(iv) |
it is not a controlled foreign corporation related to the Company as described in Section 881(c)(3)(C) of the Code. |
The undersigned has furnished the Company with a certificate of its non-U.S. Person status on IRS W-8BEN-E.
|
[Noteholder] |
|
|
By: ______________________________________ |
|
|
|
Name: |
|
|
Title: |
Date: ________ __, ____
Exhibit C
(to Supplement)
Disclosure Materials
None.
Schedule 5.3
(to Supplement)
Organization and Ownership of Shares of Subsidiaries
None.
Schedule 5.4
(to Supplement)
Financial Statements
|
|
• |
Form 10-Q filed by Spire Inc., Spire Missouri Inc. and Spire Alabama Inc. for the quarterly periods ended December 31, 2018, March 31, 2019 and June 30, 2019: xxxx://xxxxxxxxx.xxxxxxxxxxx.xxx/xxxxxxx-xxx-xxxxxxx/xxx-xxxxxxx |
|
|
• |
Form 10-K filed by Spire Inc., Spire Missouri Inc. and Spire Alabama Inc. for the year ended September 30, 2017: xxxx://xxxxxxxxx.xxxxxxxxxxx.xxx/xxxxxxx-xxx-xxxxxxx/xxx-xxxxxxx |
|
|
• |
Form 10-K filed by Spire Inc., Spire Missouri Inc. and Spire Alabama Inc. for the year ended September 30, 2018: xxxx://xxxxxxxxx.xxxxxxxxxxx.xxx/xxxxxxx-xxx-xxxxxxx/xxx-xxxxxxx |
|
|
• |
Form 10-K filed by Spire Inc., Spire Missouri Inc. and Spire Alabama Inc. for the year ended September 30, 2019: xxxx://xxxxxxxxx.xxxxxxxxxxx.xxx/xxxxxxx-xxx-xxxxxxx/xxx-xxxxxxx |
Schedule 5.5
(to Supplement)
Existing Indebtedness
|
Issue Date |
Maturity Date |
Principal Amount |
Interest Rate |
|
12/1/2015 |
12/1/2045 |
$80,000 |
4.31% |
|
1/14/2005 |
1/15/2020 |
$40,000 |
5.20% |
|
12/22/2011 |
12/22/2021 |
$50,000 |
3.86% |
|
9/15/2015 |
9/15/2025 |
$35,000 |
3.21% |
|
1/15/2007 |
1/15/2037 |
$45,000 |
5.90% |
|
1/12/2018 |
1/15/2048 |
$45,000 |
3.92% |
|
1/15/2019 |
1/15/1949 |
$90,000 |
4.64% |
|
12/1/2017 |
1/15/2058 |
$30,000 |
4.02% |
|
|
|
$415,000 |
4.43% |
Short-term borrowings from Parent, as of 6/30/19$79,600,000
Schedule 5.15
(to Supplement)
